Tafil (Alprazolam) Tablets 1Mg With 30

Category

Psychopharmaceuticals

Line

Anxiolytics

Brand

Tafil

Molecule

Alprazolam

Presentation

1 mg tablets, bottle with 30 tablets

Laboratory

Pfizer

Indications

Tafil (Alprazolam) is indicated for the treatment of anxiety disorders, including generalized anxiety disorder and panic disorder. This medication acts on the central nervous system, producing a sedative and anxiolytic effect. Its use is recommended in situations of acute anxiety, as well as in the treatment of symptoms related to anxiety disorder associated with depression. Additionally, it can be useful in the management of withdrawal symptoms in substance dependence syndrome.

Composition

Each Tafil tablet contains 1 mg of Alprazolam as the active ingredient, as well as excipients that facilitate its formulation and stability.

Contraindications

This medication is contraindicated in patients with known hypersensitivity to Alprazolam or to any of the components of the formula. It should not be administered to patients with myasthenia gravis, or to those with severe respiratory insufficiency, sleep apnea syndrome, or in cases of intoxication by central nervous system depressant medications.

Precautions

Caution should be exercised when administering Tafil to patients with a history of substance dependence, as well as to those with liver or kidney problems. Alcohol consumption should be avoided during treatment, as it can enhance the sedative effects of the medication. Likewise, its use in the geriatric population should be considered, as they may be more sensitive to the effects of Alprazolam.

Storage

Store in a cool, dry place, at a temperature not exceeding 30°C. Keep out of reach of children and do not use after the expiration date indicated on the packaging.

Requires a prescription.

Consult your doctor.